Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of an Executive Director's connected person, in the American Depositary Shares (ADS) of GlaxoSmithKline plc as a result of an award made under the GlaxoSmithKline 2009 Performance Share Plan (Performance Share Plan) on 11February 2015 as follows:
Executive Director |
Name of Connected Person |
ADS |
Dr M Slaoui |
Mrs K Slaoui |
2,030 |
The Performance Share Plan award was based on an ADS price of US$46.21 (the closing price quoted on the New York Stock Exchange on 11 February 2015). Vesting of the award is subject to meeting performance criteria over a three year period.
The Company and the above named person were advised of these transactions on 12 February 2015.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
VA Whyte
Company Secretary
12 February 2015